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Abstract
L-Dopa is the drug of choice in the
treatment of Parkinson’s disease but it
has dose related adverse effects such
as nausea, vomiting, orthostatic
hypotension, end of dose deterioration,
on off phenomena and on chronic
therapy motor complications synony-
mous to parkinsonism. Mucuna
pruriens (M.P) commonly known as
velvet beans or cowitch are  used in
case of spasms associated with Parkins
onism. Clinical efficacy of seeds of this
plant was confirmed and the efficacy
was contributed to its L-Dopa content.
M.P extract showed twice the
antiparkinsonism activity compared
with synthetic L-Dopa. There is
sufficient L-Dopa in broad bean (Vicia
faba) pods. One study proved its
efficacy in Parkinsonism.  Ginkgo biloba
extract showed protective effect in
vivo and invitro. 50% ethanolic extract
of Plumbago zeylanica was effective in
rats. The following plants were
reported to have L-Dopa but their
protective effect is yet to be established
in animal models. Vigna aconitifolia,
Vigna unguiculata, Vigna vexillata,
Prosopis chilensis,  Pileostigma
malabarica, Phanera vahlis, Parkinsonia
acculeata, Macuna urens, Canvavalia
glandiata, Cassia floribanda, Casia




Parkinson’s disease is a degenerative
neurological disease affecting about 1%
of the world population over 65 years
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of age1.  In Parkinson’s disease,
nigrostriatal dopamine degeneration
occurs2. Parkinson’s disease is
characterized by the presence of tremor,
muscular rigidity, bradykinesia,
difficulty in balance and walking,
depression and dementia4. As per
historical evidence, Parkinson’s disease
existed in ancient India and was called
kampavata2. The disease acquired its
present name from James Parkinson
who described the disease in 1817 AD5.
Allopathic medicine such as L-Dopa is
the drug of choice in the treatment of
Parkinsonism and has adverse effects
including gastro intestinal side effects
such as vomiting, nausea, giddiness3
and orthostatic hypotension abnormal
movements, behavioural adverse
effect, end of dose deterioration or the
on-off phenomenon with motor
complications synonymous with the
disease itself 4,1. To overcome the




1.  Mucuna pruriens (MP): - Mucuna
Pruriens commonly known as velvet
beans (or) co-witch is used in case of
spasms associated with Parkinsonism
(or) Bell’s palsy3. L-Dopa is extracted
from various mucuna seeds which
have reported the yield of L–dopa as
1.9% where as a simple hot water
extraction method that gave excellent
recovery of L- Dopa (3.1-6.1%) from
the seeds of nine species of mucuna5.
MP extract showed twice the anti-
parkinson’s activity, compared with
synthetic L-Dopa in including CLR in
the Parkinsonian animal model MP
extract has been reported to contain
unidentified antiparkinsonian comp-
ounds in addition to L-Dopa (or)
adjuvant responsible to enhance the
efficacy of L-Dopa4. On quantitative
evaluation, MP had a quick  onset of
action and  significantly more active
than L-dopa6.
2.  Ginkgo biloba: The neuroprotective
effects of a standardized extract of
Ginkgo biloba were investigated on 6-
hydroxy dopamine (6-OHDA) induced
neurotoxicity in the nigrostriatal
dopaminergic system of the rat brain.
A significant improvement was
observed in rats that were treated with
higher doses of Ginkgo biloba (100mg/
kg daily) than in those treated with
lower doses (50mg/kg) (or) with
vehicle. It indicates a possible role for
the extract in the treatment of
Parkinson’s disease7.
3.  Vicia faba: In 1913, Guggenheim
first isolated dihydroxy phenylalanine
in its levorotatory form from the
extracts of Vicia faba beans. Recent
studies have established the dose-
response L-Dopa absorption charact-
eristics of Vicia faba. In single-dose
studies researchers have evaluated
patients with pronounced “on – off”
motor oscillations for the beneficial
effect3.
4. Vitex negundo: Petroleum ether, n-
butanol extracts of roots of (Vitex
negundo) produced moderate CNS
depression in experimental albino
mice. Laboratory studies showed that
butanolic and ethanolic extracts produced
marked antiparkinsonian effect8.
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5. Acantho panax senticosus (ASH) :
A single dose administration of the
plant extract elevated the nor-
adrenaline and dopamine level in the
whole brain of rats in a dose
dependent manner. A single (or) 2
weeks administration of ASH (500mg/
kg) showed a marked increase in
Dopamine level in the striatum and
antiparkinsonian activity9.
6.  Ginseng: Neuroprotective action of
the ginseng extract was examined in
two rodent animal models in
Parkinson’s disease. Ginseng recently
demonstrated to possess neurop
rotective properties which may be
useful in preventing various forms of
neuronal cell loss including the
nigrostriatal degeneration seen in
Parkinson’s disease3.
7. Plumbago zeylanica: 50% ethanol
extract of the root of Plumbago
zeylanicum specifically enhanced the
spontaneous ambulatory activity
without inducing stereotypic
behaviour. It showes elevated levels of
dopamine in striatum compared with
the control rats brain3.
8.  Female Palm of Borassus flebellifer:
Aqueous and ethanolic  extract
prepared from the plant and aqueous
infusion prepared from the roots of
female palm did not show the anti
Parkinson’s activity in mice animal
model.
9.  Catechins: Five types of catechins
showed different effects11 .
Table 1 : Plants reported to contain L-Dopa .
Plant Plant  part  L-Dopa 
(%) 
Ref. 
Alysicarpus rugosus.  Seed  0.65  5 
Bauhinia purpurea.  Seed  2.2  5 
Bauhinia racemosa.  Seed  0.73  4 
Canavalia ensiformis.  Seed  2.46  4 
Canavalia gladiata.  Seed  2.13  5 
Cassia floribunda.  Seed  1.1-1.9  5 
Cassia hirsute.  Seed  2.37-2.82  4 
Dalbergia retusa.  Seed  2.2  4 
Glycine wightii.  Seed  0.2  5 




Mucuna aterrima.   Seed  3.31  6 
Mucuna aterrima.   Seed (black)  4.2  5 
Mucuna birdwoodina tutcher  Seed  9.1  14 
Mucuna cochinchinensis.  -  0.96  5 
Mucuna cochinchinensis.  Seed(ash)  4.2  6 
 Pericarp(ash)  0.14   
 Leaf(ash)  0.18   
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()
 Stem(ash)  0.28   
 Root  (ash)  0.14   
 
Mucuna cochinensis. 
Seed(grey) 205  5 
 
Mucuna cochinensis. 
Seed 3-4  6,13 
Mucuna deeringiana.  Seed  2.7-3.13  14,6 
Mucuna gigantean  Seed  1.50-3.78  5,14 
Mucuna holtonii.  Seed  6.13-7.5  14,13 
Mucuna monosperma.  Seed  4.24-4.56  6 
Mucuna mutisiana.  Seed  3.9-6.8  5 
Mucuna pruriens.  Seed (excluding 
seed coat) 
5.9-6.4 13 
Mucuna pruriens.  Seed  1.25-9.16  5 
Mucuna pruriens.  Seed (black.)  3.8  6 
 Pericarp  0.09-0.22  12 
 Leaf  0.35   
 Stem  0.31   
 Root  0.16   
Mucuna pruriens.  Whole bean  4.02   
 Endocarp  5.28  12 
Mucuna pruriens f. hirsute  Seed  1.4-1.5  4,13 
Mucuna pruriens f.utilis  Seed  1.8  4 
Mucuna pruriens var. utilis.  White(Whole seed)  4.96  4,12 
Mucuna pruriens var. utilizes   Seed (White)  6.08  13 
      
Mucuna pruriens var. utilizes   Seed (spotted)  3.6  6 
 Pericarp  0.16   
 Leaf  0.17   
 Stem  0.19   
 Root  0.12   
Mucuna sloanei   Seed  3.34-9.0  5,13 
Mucuna sp  Seed  1.96-4.96  6 
Mucuna urens.  Seed  4.92-7.4  4,5 
Parkinsonia aculeate.  Seed  0.64  5,13 
Phanera vahlii.  Seed  2.35  5 
Pileostigma malabarica.  Seed  2.13  5 
Prosopis chilensis.  Seed  1.25  5 
Abstract Park neurone in the ageing 
cerebellum 
Seed   5 
  Green peel of pod  0.2-0.75  5 
 Flowering  green 
plant 
0.09  






Vicia faba var minor  Dry seed  0.07  5 
 Green  pods  (whole 
unripe fruit) 
0.60  
  Green plant with 
pods 
0.56  
 Green  flowering 
plant 
0.40-0.46  
 Green  vegetative 
plant 
0.24-0.57  
Vicia narbonensis.  Green pods (peel 
only) 
0.5 5 
  Green plant with 
pods  
0.6  
Vigna aconitifolia.  Seed  0.20  5 
Vigna unguiculata.  Seed  0.45  5 
Vigna vexillata.  Seed  0.52-0.58  5 
Conclusion :
The presence of L-dopa which was
previously thought to be  available only
in Mucuna and Vicia is also isolated
from many other plants beyond these
two genera.  Besides these two genera,
other plants like Phanera, Pileostigma,
Cassia, Canavalia, Dalbergia etc also
have the principles that can be
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exploited for the production of
L-dopa. However, higher amount of
L-dopa is noticed only in Mucuna
species. A systemic screening of these
plants may provide an alternative to
synthetic L-dopa opening new
avenues for herbal cultivation and
therapies.
Pages 50- 5555
7. Kim MS, Lee JI, Kim SE. Neuroprotective effect of Ginkgo biloba leaf extract in a rat
model of Parkinson’s disease. Phy.ther.Res.2004, 18(8), 663-666.
8. Ravishanker B, Bhaskaran Nair R, Sasikala CK. Pharmacology of Vitex negudo root.
Journal of Res.Ayur.Siddha.1986, 7(1-2), 62-77.
9. Fujikawa T, Soya H, Hibasami H, Kawashima H, Takeda H, Nishibes Nakashima K
.Effect of Acanthopanax Senticosus harms on bipgenic monoamine levels in the rat
brain.Phy.ther.Res.2002, 16(5), 474-478.
10. Ravishanker B, Makwana HG, Nair RB, Vijayan NP, Sasikalas CK, Saraswathi VN,
Sulochana S. Some pharmacological studies on female palm of Borassus flabellifer.
Journal of Res. Ayur. Siddha. 1989, 10(1-2), 75-86.
11. Jin CF, Shen SR, Zhao BI. Different effects of five catechine on 6-OHDA-induced
apoptosis in PC12 cells. Journal of Agri. and food chem.2001, 49(12), 6033-6038.
12. Mahanjani SS, Doshi VJ, Parikh KM, Manyam BV. Bioavailability of L-dopa from HP-
200.Phy.ther.Res. 1996, 10, 254.
13. Misra L, Mishra HO, Wagner H.  Biologically active principles from Mucuna pruriens
seeds. IUPAC international conference on biodiversity and natural products chemistry
and medicinal applications.2004, 26-31, 213.
14. Ashok DB, Vadiya. The status and scope of Indian medicinal plants acting on CNS.
Ind. J.  Pharmacol. 1997, 29(5), 5340-5343
Pages 50- 55